Literature DB >> 16880616

Indole-3-acetic acid/horseradish peroxidase-induced apoptosis involves cell surface CD95 (Fas/APO-1) expression.

Dong-Seok Kim1, So-Young Kim, Yun-Mi Jeong, Sang-Eun Jeon, Myo-Kyoung Kim, Sun-Bang Kwon, Kyoung-Chan Park.   

Abstract

Recently, we showed that a combination of indole-3-acetic acid (IAA) and horseradish peroxidase (HRP) produces hydrogen peroxide (H2O2), and that this leads to the apoptosis of G361 human melanoma cells. In the present study, flow cytometric analysis confirmed that H2O2 is involved the IAA/HRP-induced apoptotic process. We also found that IAA/HRP increases cell surface CD95 (Fas/APO-1) expression, and that this is blocked by catalase treatment. Furthermore, blocking CD95 with a neutralizing antibody significantly restored IAA/HRP-induced apoptosis. In addition, the IAA/HRP-induced activations of CD95 downstream molecules, i.e., caspase-8, Bid, and caspase-3, were also inhibited by catalase. Moreover, a caspase-8 inhibitor significantly blocked IAA/HRP-induced apoptosis. These results indicate that IAA/HRP-induced apoptosis involves a CD95-initiated death receptor signaling pathway initiated by hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880616     DOI: 10.1248/bpb.29.1625

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy.

Authors:  Gema Vivo-Llorca; Ángela Morellá-Aucejo; Alba García-Fernández; Paula Díez; Antoni Llopis-Lorente; Mar Orzáez; Ramón Martínez-Máñez
Journal:  Int J Nanomedicine       Date:  2022-01-26

Review 2.  An updated view on horseradish peroxidases: recombinant production and biotechnological applications.

Authors:  Florian W Krainer; Anton Glieder
Journal:  Appl Microbiol Biotechnol       Date:  2015-01-11       Impact factor: 4.813

3.  Enzyme prodrug therapy: cytotoxic potential of paracetamol turnover with recombinant horseradish peroxidase.

Authors:  Diana Humer; Oliver Spadiut
Journal:  Monatsh Chem       Date:  2021-10-05       Impact factor: 1.451

4.  Recombinant horseradish peroxidase variants for targeted cancer treatment.

Authors:  Günther Bonifert; Lisa Folkes; Christoph Gmeiner; Gabi Dachs; Oliver Spadiut
Journal:  Cancer Med       Date:  2016-03-15       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.